These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38913228)

  • 1. Chloramphenicol treatment revisited - demographics, clinical characteristics, and outcomes of hospitalized patients.
    Ben-Chetrit E; Bnaya A; Barchad OW; Vedder K; Katz DE
    Eur J Clin Microbiol Infect Dis; 2024 Aug; 43(8):1667-1671. PubMed ID: 38913228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem.
    Holsen MR; Wardlow LC; Bazan JA; Fussner LA; Coe KE; Elefritz JL
    Int J Antimicrob Agents; 2019 Dec; 54(6):824-828. PubMed ID: 31319191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime.
    Chanderraj R; Admon AJ; He Y; Nuppnau M; Albin OR; Prescott HC; Dickson RP; Sjoding MW
    JAMA Intern Med; 2024 Jul; 184(7):769-777. PubMed ID: 38739397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient therapy with piperacillin/tazobactam using elastomeric pumps in patients with Pseudomonas aeruginosa infection.
    Ferreiro JLL; Otero JÁ; Rivo AS; González LG; Conde IR; Soneira MF; García JP; de la Fuente Aguado J
    Sci Rep; 2021 Apr; 11(1):8610. PubMed ID: 33883671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing
    Benanti GE; Brown ART; Shigle TL; Tarrand JJ; Bhatti MM; McDaneld PM; Shelburne SA; Aitken SL
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the effectiveness of two piperacillin-tazobactam molecules in the real world.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME
    Int J Infect Dis; 2018 Nov; 76():91-96. PubMed ID: 30244077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia.
    Lai CC; Chen WC; Kuo LK; Wang YT; Fu PK; Ku SC; Fang WF; Chen CM; Tu CY; Cheng WC; Chen CH
    Medicine (Baltimore); 2023 Jul; 102(28):e34284. PubMed ID: 37443505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
    Dela Pena AS; Asperger W; Köckerling F; Raz R; Kafka R; Warren B; Shivaprakash M; Vrijens F; Giezek H; DiNubile MJ; Chan CY;
    J Gastrointest Surg; 2006 Apr; 10(4):567-74. PubMed ID: 16627223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
    Huang CT; Chen CH; Chen WC; Wang YT; Lai CC; Fu PK; Kuo LK; Chen CM; Fang WF; Tu CY; Ku SC
    Int J Antimicrob Agents; 2022 Jan; 59(1):106491. PubMed ID: 34871744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study.
    Al Muqati H; Al Turaiki A; Al Dhahri F; Al Enazi H; Althemery A
    J Infect Public Health; 2021 Mar; 14(3):306-310. PubMed ID: 33618274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock.
    Le C; Chu F; Dunlay R; Villar J; Fedullo P; Wardi G
    Am J Emerg Med; 2018 Aug; 36(8):1380-1385. PubMed ID: 29321120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
    Siami FS; LaFleur BJ; Siami GA
    Clin Ther; 2002 Jan; 24(1):59-72. PubMed ID: 11833836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of continuous infusion of piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against Enterobacterales and Pseudomonas aeruginosa.
    Cojutti PG; Morandin E; Baraldo M; Pea F
    Int J Antimicrob Agents; 2021 Oct; 58(4):106408. PubMed ID: 34314808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem versus piperacillin-tazobactam for the treatment of pancreatic necrosis.
    Racketa S; Gandhi K; Lambie M
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116209. PubMed ID: 38458097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia.
    Weber N; Jackson K; McWhinney B; Ungerer J; Kennedy G; Lipman J; Roberts JA
    J Infect Chemother; 2019 Jul; 25(7):503-508. PubMed ID: 30879981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
    McKamey L; Venugopalan V; Cherabuddi K; Borgert S; Voils S; Shah K; Klinker KP
    Int J Antimicrob Agents; 2018 Nov; 52(5):719-723. PubMed ID: 30125680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study.
    Meier N; Munch MW; Granholm A; Perner A; Hertz FB; Venkatesh B; Hammond NE; Li Q; De Bus L; De Waele J; Kauzonas E; Sjövall F; Møller MH; Helleberg M
    Acta Anaesthesiol Scand; 2024 Jul; 68(6):821-829. PubMed ID: 38549422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
    Kaye KS; Belley A; Barth P; Lahlou O; Knechtle P; Motta P; Velicitat P
    JAMA; 2022 Oct; 328(13):1304-1314. PubMed ID: 36194218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
    D'Angelica MI; Ellis RJ; Liu JB; Brajcich BC; Gönen M; Thompson VM; Cohen ME; Seo SK; Zabor EC; Babicky ML; Bentrem DJ; Behrman SW; Bertens KA; Celinski SA; Chan CHF; Dillhoff M; Dixon MEB; Fernandez-Del Castillo C; Gholami S; House MG; Karanicolas PJ; Lavu H; Maithel SK; McAuliffe JC; Ott MJ; Reames BN; Sanford DE; Sarpel U; Scaife CL; Serrano PE; Smith T; Snyder RA; Talamonti MS; Weber SM; Yopp AC; Pitt HA; Ko CY
    JAMA; 2023 May; 329(18):1579-1588. PubMed ID: 37078771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.